Arrowhead Research | ARWR - Trade Debtors



Arrowhead Research reported $9.7M in Trade Debtors for its fiscal quarter ending in June of 2025.


Trade Debtors Change Date
Agios Pharmaceuticals USD 4.99M 1.64M Jun/2025
Alnylam Pharmaceuticals USD 567.11M 149.08M Jun/2025
Arrowhead Research USD 9.7M 7.33M Jun/2025
Incyte USD 842.89M 19.76M Jun/2025
Ionis Pharmaceuticals USD 52.58M 12.87M Jun/2025
Ligand Pharmaceuticals USD 42.12M 715K Jun/2025
Merck USD 12.72B 1.14B Jun/2025
Moderna USD 457M 151M Jun/2025
Novartis USD 9.18B 451M Jun/2025
Sarepta Therapeutics USD 609.6M 114.93M Jun/2025
TG Therapeutics USD 231.52M 102.33M Jun/2025
Ultragenyx Pharmaceutical USD 124.46M 25.62M Jun/2025
Vertex Pharmaceuticals USD 1.89B 88.4M Jun/2025
Xencor USD 47.55M 9.77M Jun/2025